Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5187808
Max Phase: Preclinical
Molecular Formula: C42H36ClN9O6S
Molecular Weight: 830.33
Associated Items:
ID: ALA5187808
Max Phase: Preclinical
Molecular Formula: C42H36ClN9O6S
Molecular Weight: 830.33
Associated Items:
Canonical SMILES: Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc3c(c1)C(=O)N(CCNc1cccc4c1C(=O)N(C1CCC(=O)NC1=O)C4=O)C3)c1nnc(C)n1-2
Standard InChI: InChI=1S/C42H36ClN9O6S/c1-20-21(2)59-42-34(20)36(23-7-10-25(43)11-8-23)46-30(37-49-48-22(3)51(37)42)18-33(54)45-26-12-9-24-19-50(39(56)28(24)17-26)16-15-44-29-6-4-5-27-35(29)41(58)52(40(27)57)31-13-14-32(53)47-38(31)55/h4-12,17,30-31,44H,13-16,18-19H2,1-3H3,(H,45,54)(H,47,53,55)/t30-,31?/m0/s1
Standard InChI Key: OECWVCYUBANAEX-FSRLHOSWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 830.33 | Molecular Weight (Monoisotopic): 829.2198 | AlogP: 5.30 | #Rotatable Bonds: 9 |
Polar Surface Area: 188.06 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 3 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.59 | CX Basic pKa: 4.12 | CX LogP: 4.51 | CX LogD: 4.51 |
Aromatic Rings: 5 | Heavy Atoms: 59 | QED Weighted: 0.17 | Np Likeness Score: -1.05 |
1. Guo L, Zhou Y, Nie X, Zhang Z, Zhang Z, Li C, Wang T, Tang W.. (2022) A platform for the rapid synthesis of proteolysis targeting chimeras (Rapid-TAC) under miniaturized conditions., 236 [PMID:35397401] [10.1016/j.ejmech.2022.114317] |
Source(1):